1
|
Al Riyami MS, Al Shuaibi A, Al Jardani S, Elfar A, Al Maskari A, Al Gaithi B, Al Saidi S, Al Kalbani N. Childhood Hypertension: A Retrospective Analysis of Causes, Treatments, and Complications. CHILDREN (BASEL, SWITZERLAND) 2024; 11:1234. [PMID: 39457199 PMCID: PMC11505861 DOI: 10.3390/children11101234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/19/2024] [Revised: 10/06/2024] [Accepted: 10/10/2024] [Indexed: 10/28/2024]
Abstract
BACKGROUND Hypertension is prevalent in the pediatric population, with estimated rates between 2% and 5%, and its incidence is rising globally. This study offers a single-center analysis of hypertension in children. METHODS a retrospective chart review was conducted involving children aged 1 month to 13 years diagnosed with hypertension. RESULTS The study included a total of 129 children. Secondary hypertension was identified in 103 patients (79.8%), while primary hypertension was noted in 26 patients (20.2%). Primary hypertension was more common among pre-teen children (50.0%), whereas secondary hypertension predominantly affected those aged 1 to 5 years. Renal parenchymal disease emerged as the most frequent etiology of secondary hypertension, followed by endocrine disorders and vascular issues. No significant correlation was found between hypertension and obesity. The primary complications associated with hypertension in these children were cardiovascular, followed by neurological issues. A small proportion (14.7%) managed their hypertension solely through lifestyle modifications, while the majority required additional antihypertensive medications. At the final follow-up, 50% of the children demonstrated improved blood pressure readings. CONCLUSION The findings indicate a higher prevalence of secondary hypertension compared to primary hypertension among the studied population. This study underscores the necessity for heightened awareness among pediatricians regarding the early identification and management of hypertension. Larger population-based studies are warranted to further investigate the prevalence, causes, and outcomes of hypertension in this region.
Collapse
Affiliation(s)
- Mohamed S. Al Riyami
- Pediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat P.O. Box 1331, Oman; (A.A.S.); (S.A.J.); (A.E.); (A.A.M.); (B.A.G.); (S.A.S.); (N.A.K.)
- Pediatric Residency Training Program, Oman Medical Specialty Board, Muscat P.O. Box 1422, Oman
| | - Aisha Al Shuaibi
- Pediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat P.O. Box 1331, Oman; (A.A.S.); (S.A.J.); (A.E.); (A.A.M.); (B.A.G.); (S.A.S.); (N.A.K.)
| | - Suad Al Jardani
- Pediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat P.O. Box 1331, Oman; (A.A.S.); (S.A.J.); (A.E.); (A.A.M.); (B.A.G.); (S.A.S.); (N.A.K.)
| | - Asma Elfar
- Pediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat P.O. Box 1331, Oman; (A.A.S.); (S.A.J.); (A.E.); (A.A.M.); (B.A.G.); (S.A.S.); (N.A.K.)
| | - Anisa Al Maskari
- Pediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat P.O. Box 1331, Oman; (A.A.S.); (S.A.J.); (A.E.); (A.A.M.); (B.A.G.); (S.A.S.); (N.A.K.)
| | - Badria Al Gaithi
- Pediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat P.O. Box 1331, Oman; (A.A.S.); (S.A.J.); (A.E.); (A.A.M.); (B.A.G.); (S.A.S.); (N.A.K.)
- Pediatric Residency Training Program, Oman Medical Specialty Board, Muscat P.O. Box 1422, Oman
| | - Sulaiman Al Saidi
- Pediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat P.O. Box 1331, Oman; (A.A.S.); (S.A.J.); (A.E.); (A.A.M.); (B.A.G.); (S.A.S.); (N.A.K.)
- Pediatric Residency Training Program, Oman Medical Specialty Board, Muscat P.O. Box 1422, Oman
| | - Naifain Al Kalbani
- Pediatric Nephrology Unit, Department of Child Healthy, Royal Hospital, Muscat P.O. Box 1331, Oman; (A.A.S.); (S.A.J.); (A.E.); (A.A.M.); (B.A.G.); (S.A.S.); (N.A.K.)
- Pediatric Residency Training Program, Oman Medical Specialty Board, Muscat P.O. Box 1422, Oman
| |
Collapse
|
2
|
Pacheco JA, Molena KF, Veiga EV. Photobiomodulation for Blood Pressure and Heart Rate Reduction in Mastectomized Women on Hormone Blockers: A Randomized Controlled Trial. Photobiomodul Photomed Laser Surg 2024; 42:294-305. [PMID: 38530295 DOI: 10.1089/photob.2023.0136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/27/2024] Open
Abstract
Objective: To assess the impact of intravascular laser irradiation of blood (ILIB) on the primitive carotid artery (PCA) hemodynamic variables, specifically blood pressure (BP) and heart rate (HR), in mastectomized patients undergoing hormone blocker treatments. Materials and methods: This study is a controlled, experimental, and randomized clinical trial. Patients were allocated into two groups: the experimental group (G1)-patients who received ILIB therapy using a 660 nm laser targeted at the PCA, and the control group (G2)-patients who did not receive ILIB therapy. Clinical research was conducted weekly, with measurements of systolic blood pressure (SBP), diastolic blood pressure (DBP), and HR. The Mann-Whitney U test for independent samples was used, with a significance level of α = 0.05. Results: Systemic photobiomodulation on the PCA did not demonstrate a statistically significant difference in relation to SBP and DBP. However, for HR, the p-value was <0.05, indicating a significant difference between G1 and G2. The initial mean p > decreased from 142.3 to 116.4 mmHg in G1, and from 130.4 to 119.8 mmHg in G2. The DBP varied from 78.8 to 72.8 mmHg in G1, and from 79.1 to 74.2 mmHg in G2. A statistically significant difference was observed in HR, decreasing from 81.3 to 62.06 bpm in G1, and changing minimally from 74.1 to 75.1 bpm in G2. A considerable reduction was present in the timing of application. Conclusions: ILIB therapy applied to the PCA induces a reduction in BP and, more notably, HR in mastectomized women using the tamoxifen or aromatase inhibitors.
Collapse
Affiliation(s)
- Juliano Abreu Pacheco
- Department of General and Specialized Nursing, Postgraduate Program, Ribeirão Preto College of Nursing, University of São Paulo, Ribeirão Preto, Brazil
- Ribeirão Preto Cancer Hospital, Sobeccan Hospital Foundation, Ribeirão Preto, Brazil
| | - Kelly Fernanda Molena
- Department of Pediatric Dentistry, Postgraduate Program in Pediatric Dentistry, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil
| | - Eugenia Velludo Veiga
- Department of General and Specialized Nursing, Ribeirão Preto College of Nursing, University of São Paulo, Ribeirão Preto, Brazil
| |
Collapse
|
3
|
Snyder EM, Kelley EF, Sprissler R, Olson TP. The importance and challenges of developing a pharmacogenetics test for hypertension. Pharmacogenomics 2019; 20:563-566. [PMID: 31136254 DOI: 10.2217/pgs-2019-0056] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Affiliation(s)
| | - Eli F Kelley
- School of Kinesiology, University of Minnesota, Minneapolis, MN 55455, USA
| | - Ryan Sprissler
- Geneticure, Inc., Rochester, MN 55902, USA.,University of Arizona Genomics Core, Tucson, Arizona, AZ 85721 USA
| | - Thomas P Olson
- Geneticure, Inc., Rochester, MN 55902, USA.,Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
| |
Collapse
|